In docetaxel-resistant LUAD cells, miR-100-5p inhibits PLK1 to modulate resistance (Feng, Wang & Chen, 2012); this also in NSCLC, miR-100-5p targets PLK1 to attenuate growth, arrest the G2/M phase, and enhance apoptosis (Liu et al., 2012). The gene discussed is PLK1; the disease is non-small cell lung carcinoma.